$4.20
-0.16[-3.67%]
Last update: 4:11PM Get Real Time Here
Edesa Biotech
(NASDAQ:EDSA)Latest News for Edesa Biotech Stock (NASDAQ:EDSA)
Edesa Biotech Stock (NASDAQ: EDSA)
Categories: All
Wednesday, February 14, 2024
Friday, December 15, 2023
Wednesday, December 13, 2023
Wednesday, November 29, 2023
Wednesday, November 22, 2023
Monday, November 20, 2023
Wednesday, October 25, 2023
Friday, October 13, 2023
- Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Oct 13, 2023, 1:14PM
- Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About YetChris Katje - Oct 13, 2023, 10:26AM
- Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 13, 2023, 7:35AM
Thursday, October 12, 2023
- Why Is Infectious Disease Player Edesa Biotech Stock Soaring Today?Vandana Singh - Oct 12, 2023, 2:10PM
- Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Oct 12, 2023, 12:55PM
- Edesa Biotech Shares Halted On Circuit Breaker To The Upside, Stock Now Up 83.3%Benzinga Newsdesk - Oct 12, 2023, 12:17PM
- Edesa Biotech Secures $10M Credit Facility With Company FounderBenzinga Newsdesk - Oct 12, 2023, 12:17PM
- Edesa Biotech To Receive Up To CAD $23M In Funding From Federal GovernmentBenzinga Newsdesk - Oct 12, 2023, 12:16PM
Tuesday, October 10, 2023
Thursday, September 28, 2023
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Sep 28, 2023, 2:32PM
- Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Sep 28, 2023, 1:04PM
- Edesa Biotech shares are trading lower after the company published data from a Phase 2 substudy of its ARDS candidate.Benzinga Newsdesk - Sep 28, 2023, 10:31AM
- Edesa Biotech Publishes Phase 2 Substudy Results Of ARDS Drug CandidateBenzinga Newsdesk - Sep 28, 2023, 8:18AM
Tuesday, August 15, 2023
Wednesday, August 09, 2023
Wednesday, June 28, 2023
Tuesday, June 27, 2023
Wednesday, May 24, 2023
Wednesday, May 17, 2023
Wednesday, March 15, 2023
- HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $16 Price TargetBenzinga Newsdesk - Mar 15, 2023, 9:23AM
- Edesa Biotech And FDA Agree On Primary Endpoint For Phase 3 ARDS Drug Study, Says 28-Day Survival will Be Evaluated In ARDS Patients Hospitalized With COVID-19Bill Haddad - Mar 15, 2023, 8:14AM
Wednesday, February 15, 2023
Tuesday, February 14, 2023
Friday, February 10, 2023
Wednesday, February 01, 2023
Wednesday, January 18, 2023
Tuesday, January 17, 2023
- Nasdaq Edges Higher; Neovasc Shares JumpLisa Levin - Jan 17, 2023, 2:50PM
- Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jan 17, 2023, 1:21PM
- Edesa Biotech's Dermatitis Study Data Fails To Cheer InvestorsVandana Singh - Jan 17, 2023, 12:30PM
- Dow Tumbles 300 Points; Morgan Stanley Beats Q4 ViewsLisa Levin - Jan 17, 2023, 12:07PM
- Dow Drops Over 150 Points; Goldman Sachs Profit Misses ExpectationsLisa Levin - Jan 17, 2023, 9:56AM
- Edesa Biotech shares are trading lower after the company reported topline Phase 2b results for its dermatology drug.Benzinga Newsdesk - Jan 17, 2023, 8:47AM
- Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug; 1.0% Formulation Reached Primary Endpoint With Statistical Significance; Company Preparing For End Of Phase 2 Meeting With FDA Following Full AnalysisBenzinga Newsdesk - Jan 17, 2023, 8:39AM
- Edesa Biotech Reports Topline Phase 2b Results For Dermatology Drug; Study Successfully Identified Lowest Effective DoseBenzinga Newsdesk - Jan 17, 2023, 8:37AM